ArticleAnnals of medicine and surgery (2012)2025

Nipocalimab: a significant milestone in the treatment of myasthenia gravis approved by the FDA.

Sonia Irfan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.